Bullish
$SRNE on NantCell, which had issued a statement a few days earlier saying that it had received $30 million in funding from Celgene. Sorrento Therapeutics mentions in its complaint that Sorrento is also a 2.8% shareholder in NantCell, claiming its stake is worth $105 million. Nobody ever mentions this!
  • 11
  • 2